{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T21:29:19Z","timestamp":1794346159026,"version":"4.9.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sig Transduct Target Ther"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The ongoing pandemic caused by mpox virus (MPXV) has become an international public health emergency that poses a significant threat to global health. The vaccinia virus Tiantan strain (VTT) was used to vaccinate against smallpox in China 42 years ago. It is urgent to assess the level of immunity to smallpox in individuals vaccinated 43 or more years ago and evaluate their immunological susceptibility to MPXV. Here, we recruited 294 volunteers and detected the level of residual humoral immunity, including the vaccinia-specific IgG level and neutralizing antibody titer, and the cross-antibodies of MPXV A29L, B6R, A35R, and M1R. Our results showed that the humoral immunity from the smallpox vaccine in the population still remains, and VTT-specific NAb levels wane with age. The majority of the population pre-1981 who should be immunized with VTT still maintains certain levels of MPXV-specific antibodies, in particular, targeting A35R and B6R antigens. Furthermore, we separately analyzed the correlations between the OD450 values of VTT-specific IgG and A35R-specific IgG, B6R-specific IgG, and A29L-specific IgG with plasma samples diluted 1:40, showing a linear correlation (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). Our findings suggest that most Chinese populations still maintain VTT-specific IgG antibodies for 42 or more years after smallpox vaccination and could provide some level of protection against MPXV.<\/jats:p>","DOI":"10.1038\/s41392-023-01574-6","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:01:55Z","timestamp":1694736115000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Duration of humoral immunity from smallpox vaccination and its cross-reaction with Mpox virus"],"prefix":"10.1038","volume":"8","author":[{"given":"Entao","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxiang","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qizan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenyu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Chuai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9034-5755","authenticated-orcid":false,"given":"Sandra","family":"Chiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,15]]},"reference":[{"key":"1574_CR1","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.idc.2019.03.001","volume":"33","author":"E Petersen","year":"2019","unstructured":"Petersen, E. et al. Human Monkeypox: epidemiologic and clinical characteristics, diagnosis, and prevention. Infect. Dis. Clin. North Am. 33, 1027\u20131043 (2019).","journal-title":"Infect. Dis. Clin. North Am."},{"key":"1574_CR2","first-page":"165","volume":"58","author":"JG Breman","year":"1980","unstructured":"Breman, J. G. et al. Human monkeypox, 1970-79. Bull. World Health Organ. 58, 165\u2013182 (1980).","journal-title":"Bull. World Health Organ."},{"key":"1574_CR3","doi-asserted-by":"publisher","first-page":"e0010141","DOI":"10.1371\/journal.pntd.0010141","volume":"16","author":"EM Bunge","year":"2022","unstructured":"Bunge, E. M. et al. The changing epidemiology of human monkeypox-A potential threat? A systematic review. PLoS Negl. Trop. Dis. 16, e0010141 (2022).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"1574_CR4","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.3201\/eid2805.220292","volume":"28","author":"V Costello","year":"2022","unstructured":"Costello, V. et al. Imported Monkeypox from International Traveler, Maryland, USA, 2021. Emerg. Infect. Dis. 28, 1002\u20131005 (2022).","journal-title":"Emerg. Infect. Dis."},{"key":"1574_CR5","doi-asserted-by":"crossref","unstructured":"Hobson, G., et al. Family cluster of three cases of monkeypox imported from Nigeria to the United Kingdom, May 2021. Euro. Surveill. 26, 2100745 (2021).","DOI":"10.2807\/1560-7917.ES.2021.26.32.2100745"},{"key":"1574_CR6","doi-asserted-by":"publisher","first-page":"980","DOI":"10.3201\/eid2505.190076","volume":"25","author":"N Erez","year":"2019","unstructured":"Erez, N. et al. Diagnosis of imported Monkeypox, Israel, 2018. Emerg. Infect. Dis. 25, 980\u2013983 (2019).","journal-title":"Emerg. Infect. Dis."},{"key":"1574_CR7","unstructured":"WHO. WHO Director-General\u2019s statement at the press conference following IHR Emergency Committee regarding the multi-country outbreak of monkeypox\u201423 July 2022. https:\/\/www.who.int\/director-general\/speeches\/detail\/who-director-general-s-statement-on-the-press-conference-following-IHR-emergency-committee-regarding-the-multi--country-outbreak-of-monkeypox--23-july-2022. (WHO, 2022)."},{"key":"1574_CR8","unstructured":"CDC. 2022 Global Map & Case Count. https:\/\/www.cdc.gov\/poxvirus\/mpox\/response\/2022\/world-map.html. (CDC, 2023)."},{"key":"1574_CR9","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1093\/ije\/17.3.643","volume":"17","author":"PE Fine","year":"1988","unstructured":"Fine, P. E., Jezek, Z., Grab, B. & Dixon, H. The transmission potential of monkeypox virus in human populations. Int. J. Epidemiol. 17, 643\u2013650 (1988).","journal-title":"Int. J. Epidemiol."},{"key":"1574_CR10","doi-asserted-by":"publisher","first-page":"D7","DOI":"10.1016\/j.vaccine.2011.06.080","volume":"29","author":"DA Henderson","year":"2011","unstructured":"Henderson, D. A. The eradication of smallpox\u2013an overview of the past, present, and future. Vaccine 29, D7\u2013D9 (2011).","journal-title":"Vaccine"},{"key":"1574_CR11","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1469-0691.2006.01576.x","volume":"13","author":"SH Kim","year":"2007","unstructured":"Kim, S. H. et al. The persistence of humoral and cellular immunities more than three decades after smallpox vaccination. Clin. Microbiol. Infect. 13, 91\u201393 (2007).","journal-title":"Clin. Microbiol. Infect"},{"key":"1574_CR12","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.0105-2896.2006.00392.x","volume":"211","author":"IJ Amanna","year":"2006","unstructured":"Amanna, I. J., Slifka, M. K. & Crotty, S. Immunity and immunological memory following smallpox vaccination. Immunol. Rev. 211, 320\u2013337 (2006).","journal-title":"Immunol. Rev."},{"key":"1574_CR13","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1017\/S0950268813000071","volume":"142","author":"FR Mooi","year":"2014","unstructured":"Mooi, F. R., Van Der Maas, N. A. & De Melker, H. E. Pertussis resurgence: waning immunity and pathogen adaptation\u2014two sides of the same coin. Epidemiol. Infect. 142, 685\u2013694 (2014).","journal-title":"Epidemiol. Infect."},{"key":"1574_CR14","first-page":"2071","volume":"276","author":"JM Heffernan","year":"2009","unstructured":"Heffernan, J. M. & Keeling, M. J. Implications of vaccination and waning immunity. Proc. Biol. Sci. 276, 2071\u20132080 (2009).","journal-title":"Proc. Biol. Sci."},{"key":"1574_CR15","doi-asserted-by":"publisher","first-page":"e1003756","DOI":"10.1371\/journal.ppat.1003756","volume":"9","author":"SN Shchelkunov","year":"2013","unstructured":"Shchelkunov, S. N. An increasing danger of zoonotic orthopoxvirus infections. PLoS Pathog. 9, e1003756 (2013).","journal-title":"PLoS Pathog"},{"key":"1574_CR16","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3201\/eid2704.203569","volume":"27","author":"PY Nguyen","year":"2021","unstructured":"Nguyen, P. Y. et al. Reemergence of Human Monkeypox and declining population immunity in the context of urbanization, Nigeria, 2017-2020. Emerg. Infect. Dis. 27, 1007\u20131014 (2021).","journal-title":"Emerg. Infect. Dis."},{"key":"1574_CR17","doi-asserted-by":"publisher","first-page":"71","DOI":"10.2147\/DDDT.S3687","volume":"4","author":"A Nalca","year":"2010","unstructured":"Nalca, A. & Zumbrun, E. E. ACAM2000: the new smallpox vaccine for United States Strategic National Stockpile. Drug Des. Devel. Ther. 4, 71\u201379 (2010).","journal-title":"Drug Des. Devel. Ther."},{"key":"1574_CR18","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1007\/s40265-022-01742-y","volume":"82","author":"JG Rizk","year":"2022","unstructured":"Rizk, J. G. et al. Prevention and treatment of Monkeypox. Drugs 82, 957\u2013963 (2022).","journal-title":"Drugs"},{"key":"1574_CR19","doi-asserted-by":"publisher","first-page":"1768","DOI":"10.1080\/22221751.2022.2095309","volume":"11","author":"Y Xiang","year":"2022","unstructured":"Xiang, Y. & White, A. Monkeypox virus emerges from the shadow of its more infamous cousin: family biology matters. Emerg. Microbes Infect. 11, 1768\u20131777 (2022).","journal-title":"Emerg. Microbes Infect."},{"key":"1574_CR20","unstructured":"FDA. FDA Approves First Live, Nonnon-replicating Vaccine to Prevent Smallpox and Monkeypox. https:\/\/www.fda.gov\/news-events\/press-announcements\/fdaapproves-first-live-non-replicating-vaccine-prevent-smallpox-and-monkeypox. (FDA, 2019)."},{"key":"1574_CR21","doi-asserted-by":"publisher","first-page":"102019","DOI":"10.1016\/j.ttbdis.2022.102019","volume":"13","author":"X Yang","year":"2022","unstructured":"Yang, X. et al. The life cycle of Hyalomma scupense (Acari: Ixodidae) under laboratory conditions. Ticks Tick Borne Dis. 13, 102019 (2022).","journal-title":"Ticks Tick Borne Dis."},{"key":"1574_CR22","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1056\/NEJMc2211944","volume":"387","author":"M Thy","year":"2022","unstructured":"Thy, M. et al. Breakthrough infections after postexposure vaccination against Mpox. N. Engl J. Med. 387, 2477\u20132479 (2022).","journal-title":"N. Engl J. Med."},{"key":"1574_CR23","doi-asserted-by":"publisher","first-page":"2336","DOI":"10.3201\/eid2811.221215","volume":"28","author":"M Turner","year":"2022","unstructured":"Turner, M. et al. Monkeypox in patient immunized with ACAM2000 smallpox vaccine During 2022 Outbreak. Emerg. Infect. Dis. 28, 2336\u20132338 (2022).","journal-title":"Emerg. Infect. Dis."},{"key":"1574_CR24","doi-asserted-by":"publisher","first-page":"e349","DOI":"10.1016\/S1473-3099(22)00574-6","volume":"22","author":"GA Poland","year":"2022","unstructured":"Poland, G. A., Kennedy, R. B. & Tosh, P. K. Prevention of monkeypox with vaccines: a rapid review. Lancet Infect. Dis. 22, e349\u2013e358 (2022).","journal-title":"Lancet Infect. Dis."},{"key":"1574_CR25","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.virs.2022.07.006","volume":"37","author":"Q Gong","year":"2022","unstructured":"Gong, Q., Wang, C., Chuai, X. & Chiu, S. Monkeypox virus: a re-emergent threat to humans. Virol. Sin. 37, 477\u2013482 (2022).","journal-title":"Virol. Sin."},{"key":"1574_CR26","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.virs.2022.10.004","volume":"38","author":"L Yang","year":"2023","unstructured":"Yang, L. et al. Immunization of mice with vaccinia virus Tiantan strain yields antibodies cross-reactive with protective antigens of monkeypox virus. Virol. Sin. 38, 162\u2013164 (2023).","journal-title":"Virol. Sin."},{"key":"1574_CR27","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/sj.icb.7100118","volume":"86","author":"V Panchanathan","year":"2008","unstructured":"Panchanathan, V., Chaudhri, G. & Karupiah, G. Correlates of protective immunity in poxvirus infection: where does antibody stand? Immunol. Cell Biol. 86, 80\u201386 (2008).","journal-title":"Immunol. Cell Biol."},{"key":"1574_CR28","doi-asserted-by":"publisher","first-page":"214","DOI":"10.4269\/ajtmh.1972.21.214","volume":"21","author":"TM Mack","year":"1972","unstructured":"Mack, T. M., Noble, J. Jr & Thomas, D. B. A prospective study of serum antibody and protection against smallpox. Am. J. Trop. Med. Hyg. 21, 214\u2013218 (1972).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"1574_CR29","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1016\/0035-9203(72)90095-8","volume":"66","author":"JK Sarkar","year":"1972","unstructured":"Sarkar, J. K., Mitra, A. C. & Chakravarty, M. S. Relationship of clinical severity, antibody level, and previous vaccination state in smallpox. Trans. R. Soc. Trop. Med. Hyg. 66, 789\u2013792 (1972).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"1574_CR30","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1093\/infdis\/154.4.551","volume":"154","author":"Z Jezek","year":"1986","unstructured":"Jezek, Z. et al. Human monkeypox: a study of 2,510 contacts of 214 patients. J. Infect. Dis. 154, 551\u2013555 (1986).","journal-title":"J. Infect. Dis."},{"key":"1574_CR31","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1073\/pnas.0408782102","volume":"102","author":"DH Davies","year":"2005","unstructured":"Davies, D. H. et al. Profiling the humoral immune response to infection by using proteome microarrays: high-throughput vaccine and diagnostic antigen discovery. Proc. Natl Acad. Sci. USA 102, 547\u2013552 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1574_CR32","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/s12985-023-02085-0","volume":"20","author":"F Gao","year":"2023","unstructured":"Gao, F. et al. Cross-reactive immune responses to monkeypox virus induced by MVA vaccination in mice. Virol. J. 20, 126 (2023).","journal-title":"Virol. J."},{"key":"1574_CR33","first-page":"1126","volume":"71","author":"KP Delaney","year":"2022","unstructured":"Delaney, K. P. et al. Strategies adopted by gay, bisexual, and other men who have sex with men to prevent monkeypox virus transmission\u2014United States, August 2022. MMWR Morb. Mortal Wkly Rept. 71, 1126\u20131130 (2022).","journal-title":"MMWR Morb. Mortal Wkly Rept."},{"key":"1574_CR34","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/nm917","volume":"9","author":"E Hammarlund","year":"2003","unstructured":"Hammarlund, E. et al. Duration of antiviral immunity after smallpox vaccination. Nat. Med. 9, 1131\u20131137 (2003).","journal-title":"Nat. Med."},{"key":"1574_CR35","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1006\/viro.1999.0096","volume":"266","author":"JW Hooper","year":"2000","unstructured":"Hooper, J. W., Custer, D. M., Schmaljohn, C. S. & Schmaljohn, A. L. DNA vaccination with vaccinia virus L1R and A33R genes protects mice against a lethal poxvirus challenge. Virology. 266, 329\u2013339 (2000).","journal-title":"Virology."},{"key":"1574_CR36","doi-asserted-by":"publisher","first-page":"e0150421","DOI":"10.1128\/JVI.01504-21","volume":"96","author":"EM Mucker","year":"2022","unstructured":"Mucker, E. M. et al. A nucleic acid-based orthopoxvirus vaccine targeting the vaccinia virus L1, A27, B5, and A33 proteins protects rabbits against lethal rabbitpox virus aerosol challenge. J. Virol. 96, e0150421 (2022).","journal-title":"J. Virol."}],"container-title":["Signal Transduction and Targeted Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01574-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01574-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01574-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T19:02:47Z","timestamp":1700247767000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41392-023-01574-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,15]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1574"],"URL":"https:\/\/doi.org\/10.1038\/s41392-023-01574-6","relation":{},"ISSN":["2059-3635"],"issn-type":[{"value":"2059-3635","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,15]]},"assertion":[{"value":"13 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The study was reviewed and approved by the Ethics Committee of The First Affiliated Hospital of Anhui Medical University, Anhui, China (approval no. PJ2023-03-39).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"350"}}